JAMES KENT: Open Payments
NPI 1912356536 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,711 in 93 payments from 18 companies in 2025. Trend: 2023 $1,465 · 2024 $2,120 · 2025 $1,711
Food & beverage: $1,711
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $272 |
| Axsome Therapeutics, Inc. | 12 | $217 |
| Astellas Pharma US Inc | 9 | $193 |
| ABBVIE INC. | 11 | $168 |
| PFIZER INC. | 7 | $159 |
| Otsuka America Pharmaceutical, Inc. | 7 | $128 |
| Lilly USA, LLC | 5 | $88 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $85 |
| GlaxoSmithKline, LLC. | 4 | $82 |
| Exact Sciences Corporation | 4 | $65 |
Products named: Auvelity, Veozah, Wegovy, REXULTI, NURTEC ODT, VRAYLAR, Kerendia, SHINGRIX.
Industry payments across TN — which companies pay providers there.
